Associated Papers
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Carvalho Henriques B et al.
Frontiers in Genetics, 2020
Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis.
Na Takuathung M et al.
Acta Psychiatrica Scandinavica, 2019
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.
Zhou SF et al.
Drug Metabolism Reviews, 2010
Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients.
Ghotbi R et al.
European Journal of Clinical Pharmacology, 2010
Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.
Zhou SF et al.
The Aaps Journal, 2009
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
Ghotbi R et al.
European Journal of Clinical Pharmacology, 2007
Select a paper to view details